07.06.2015 Views

NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT

NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT

NOMENKLATURA E KOMBINUAR E MALLRAVE 2012 - INSTAT

SHOW MORE
SHOW LESS

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Kodi NK CAS RN Emri<br />

216503-58-1 mitumomab<br />

216669-97-5 sibrotuzumab<br />

216974-75-3 bevacizumab<br />

219649-07-7 labetuzumab<br />

219685-50-4 eculizumab<br />

219685-93-5 pexelizumab<br />

219716-33-3 visilizumab<br />

220578-59-6 gemtuzumab<br />

220651-94-5 ruplizumab<br />

235428-87-2 taplitumomab paptox<br />

241473-69-8 reslizumab<br />

242138-07-4 omalizumab<br />

244096-20-6 gavilimomab<br />

250242-54-7 lemalesomab<br />

252662-47-8 toralizumab<br />

263547-71-3 epitumomab<br />

263547-71-3 epitumomab cituxetan<br />

267227-08-7 apolizumab<br />

272780-74-2 metelimumab<br />

285985-06-0 lerdelimumab<br />

288392-69-8 siplizumab<br />

292819-64-8 ecromeximab<br />

299423-37-3 teneliximab<br />

326859-36-3 fontolizumab<br />

331243-22-2 pascolizumab<br />

331731-18-1 adalimumab<br />

336801-86-6 vapaliximab<br />

339086-80-5 tadocizumab<br />

339177-26-3 panitumumab<br />

339186-68-4 matuzumab<br />

339986-90-2 tucotuzumab celmoleukin<br />

347396-82-1 ranibizumab<br />

356547-88-1 belimumab<br />

357613-77-5 galiximab<br />

357613-86-6 lumiliximab<br />

372075-37-1 sontuzumab<br />

375348-49-5 bertilimumab<br />

375823-41-9 tocilizumab<br />

380610-22-0 talizumab<br />

380610-27-5 pertuzumab<br />

395639-53-9 aselizumab<br />

400010-39-1 cantuzumab mertansine

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!